The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins associated with Parkinsons disease. In particular, the animals or cells are generated using a zinc finger nuclease-mediated editing process. Also provided are methods of assessing the effects of agents in genetically modified animals and cells comprising edited chromosomal sequences encoding proteins associated with Parkinsons disease.